351 related articles for article (PubMed ID: 3881560)
21. A controlled trial of adjuvant chemotherapy with melphalan versus cyclophosphamide, methotrexate, and fluorouracil for breast cancer.
Howell A; Rubens RD; Bush H; George WD; Howat JM; Crowther D; Sellwood RA; Hayward JL; Knight RK; Bulbrook RD
Recent Results Cancer Res; 1984; 96():74-89. PubMed ID: 6396780
[No Abstract] [Full Text] [Related]
22. Hormone receptors. An update and application.
Hubay CA; Arafah B; Gordon NH; Guyton SP; Crowe JP
Surg Clin North Am; 1984 Dec; 64(6):1155-72. PubMed ID: 6393400
[TBL] [Abstract][Full Text] [Related]
23. Adjuvant CMFVP versus melphalan for operable breast cancer with positive axillary nodes: 10-year results of a Southwest Oncology Group Study.
Rivkin SE; Green S; Metch B; Glucksberg H; Gad-el-Mawla N; Constanzi JJ; Hoogstraten B; Athens J; Maloney T; Osborne CK
J Clin Oncol; 1989 Sep; 7(9):1229-38. PubMed ID: 2671283
[TBL] [Abstract][Full Text] [Related]
24. The use of adjuvant chemotherapy for breast cancer in a community practice.
Rosenberg A; Winer EP; Cadman E
Conn Med; 1985 May; 49(5):281-5. PubMed ID: 3839177
[No Abstract] [Full Text] [Related]
25. Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials.
Taghian A; Jeong JH; Mamounas E; Anderson S; Bryant J; Deutsch M; Wolmark N
J Clin Oncol; 2004 Nov; 22(21):4247-54. PubMed ID: 15452182
[TBL] [Abstract][Full Text] [Related]
26. Current results of the University of Arizona Adjuvant Breast Cancer trials (1974-1984).
Jones SE; Brooks RJ; Takasugi BJ; Garewal HS; Giordano GF; Ketchel SJ; Jackson R; Heusinkveld RS; Kemmer SR; Moon TE
Recent Results Cancer Res; 1984; 96():133-40. PubMed ID: 6396766
[No Abstract] [Full Text] [Related]
27. Adjuvant CMFP versus CMFP plus tamoxifen versus observation alone in postmenopausal, node-positive breast cancer patients: three-year results of an Eastern Cooperative Oncology Group study.
Taylor SG; Kalish LA; Olson JE; Cummings F; Bennett JM; Falkson G; Tormey DC; Carbone PP
J Clin Oncol; 1985 Feb; 3(2):144-54. PubMed ID: 3881561
[TBL] [Abstract][Full Text] [Related]
28. Evolving concepts in the systemic adjuvant treatment of breast cancer.
Bonadonna G
Cancer Res; 1992 Apr; 52(8):2127-37. PubMed ID: 1559216
[No Abstract] [Full Text] [Related]
29. Cancer and Leukemia Group B adjuvant chemotherapy trials in postmastectomy breast cancer patients.
Wood WC
Breast Cancer Res Treat; 1983; 3 Suppl():S39-43. PubMed ID: 6367859
[TBL] [Abstract][Full Text] [Related]
30. Adjuvant systemic therapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group's trials of cyclophosphamide or CMF in premenopausal and tamoxifen in postmenopausal patients.
Mouridsen HT; Rose C; Brincker H; Thorpe SM; Rank F; Fischerman K; Andersen KW
Recent Results Cancer Res; 1984; 96():117-28. PubMed ID: 6396765
[No Abstract] [Full Text] [Related]
31. How to improve adjuvant treatment results in postmenopausal patients.
Mouridsen HT
Recent Results Cancer Res; 1989; 115():144-52. PubMed ID: 2533698
[No Abstract] [Full Text] [Related]
32. Adjuvant chemotherapy in postmenopausal women: results of sequential noncross-resistant regimens.
Brambilla C; Rossi A; Valagussa P; Bonadonna G
World J Surg; 1985 Oct; 9(5):728-37. PubMed ID: 3840630
[No Abstract] [Full Text] [Related]
33. Maintenance tamoxifen after induction postoperative chemotherapy in node-positive breast cancer patients: the Eastern Cooperative Oncology Group Trials.
Tormey DC; Gray R; Falkson HC; Gilchrist K; Abeloff MD; Falkson G
Recent Results Cancer Res; 1993; 127():185-96. PubMed ID: 8502815
[No Abstract] [Full Text] [Related]
34. Adjuvant chemotherapy for node-negative breast cancer patients.
Bonadonna G; Zambetti M; Valagussa P
Recent Results Cancer Res; 1989; 115():175-9. PubMed ID: 2516350
[No Abstract] [Full Text] [Related]
35. Recent progress in breast cancer management. Combined modality (adjuvant) therapy.
Cowan K; Lippman M
Arch Intern Med; 1981 Jul; 141(8):1055-9. PubMed ID: 7018440
[No Abstract] [Full Text] [Related]
36. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.
Rivkin SE; Green SJ; Lew D; Costanzi JJ; Athens JW; Osborne CK; Vaughn CB; Martino S
Cancer; 2003 Jan; 97(1):21-9. PubMed ID: 12491501
[TBL] [Abstract][Full Text] [Related]
37. Natural history of more than 20 years of node-positive primary breast carcinoma treated with cyclophosphamide, methotrexate, and fluorouracil-based adjuvant chemotherapy: a study by the Cancer and Leukemia Group B.
Weiss RB; Woolf SH; Demakos E; Holland JF; Berry DA; Falkson G; Cirrincione CT; Robbins A; Bothun S; Henderson IC; Norton L;
J Clin Oncol; 2003 May; 21(9):1825-35. PubMed ID: 12721260
[TBL] [Abstract][Full Text] [Related]
38. Clinical trials referral resource. Adjuvant therapy of breast cancer.
Cheson BD
Oncology (Williston Park); 1989 Jun; 3(6):70-1, 74-5, 78. PubMed ID: 2534915
[No Abstract] [Full Text] [Related]
39. Comparison of different trials of adjuvant chemotherapy in stage II breast cancer using a natural history data base.
Jones SE; Moon TE; Bonadonna G; Valagussa P; Rivkin S; Buzdar A; Montague E; Powles T
Am J Clin Oncol; 1987 Oct; 10(5):387-95. PubMed ID: 3310603
[TBL] [Abstract][Full Text] [Related]
40. Ludwig Breast Cancer trials LBCS III and IV: adjuvant endocrine treatment in postmenopausal patients.
Goldhirsch A
Recent Results Cancer Res; 1984; 96():204-9. PubMed ID: 6549355
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]